NDC 76179-025-01 - KEDBUMIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76179-025
- Requested NDC
- 76179-025-01
- Package NDCs from labels
- 76179-025-01, 76179-025-02, 76179-025-03, 76179-025-04
- Manufacturer
- Kedrion S.p.A
- Effective date
- 2026-08-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| KEDBUMIN - Kedrion S.p.A | Kedrion S.p.A | 2026-08-20 | PLASMA DERIVATIVE |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76179-025-01 | KEDBUMIN | 50 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 50 | 17 | |
| 76179-025-02 | KEDBUMIN | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 17 | |
| 76179-025-03 | KEDBUMIN | 100 mL in 1 VIAL | INJECTION, SOLUTION | 100 | 17 | |
| 76179-025-04 | KEDBUMIN | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 17 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76179-025-01 | ML - Milliliter | 76179-025 | 05a1c14e-bbbb-428e-bb94-395b1934e490 | 1 | 2012-07-24 |
| 76179-025-02 | ML - Milliliter | 76179-025 | 0cca745e-4bcc-4f7b-b6c3-914819a3db07 | 1 | 2013-02-13 |
| 76179-025-03 | ML - Milliliter | 76179-025 | 0bd3d118-25b3-4614-8763-5500963863de | 1 | 2013-08-02 |
| 76179-025-04 | ML - Milliliter | 76179-025 | ea54b735-fc02-4044-98e8-498400f8981b | 1 | 2013-08-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ALBUMIN (HUMAN) | ACTIVE INGREDIENT | ZIF514RVZR | KEDBUMIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [KEDRION S.P.A] | 9 | |
| ALBUMIN (HUMAN) | ACTIVE MOIETY | ZIF514RVZR | KEDBUMIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [KEDRION S.P.A] | 9 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KEDBUMIN | ALBUMIN (HUMAN) | Kedrion S.p.A | 57bd6811-8619-11e0-9d78-0800200c9a66 | 2026-08-20 | Warnings, Adverse reactions | BLA125384 76179-025-04 76179-025-02 76179-025-01 76179-025-03 76179-025 76179002501 1742222 1741375 1742224 1741380 841fff1e-8512-4dce-aa5e-be7ed224cbf6 57bd6811-8619-11e0-9d78-0800200c9a66 ZIF514RVZR |
| ALBURX | ALBUMIN (HUMAN) | CSL Behring AG | 56a6ad30-153d-4adf-9d92-a82ec19fa1b8 | 2026-06-29 | Warnings, Adverse reactions | ZIF514RVZR |
| Proteinuria Drops 2053 | PROTEINURIA DROPS | Professional Complementary Health Formulas | 1bf80282-8283-4835-acd4-fbdb47788c67 | 2026-01-08 | Warnings | ZIF514RVZR |
| ALBUTEIN | ALBUMIN (HUMAN) | GRIFOLS USA, LLC | de634e31-d99b-4ed6-ba0a-07904d745aeb | 2025-05-28 | Warnings, Adverse reactions | 1741375 1741380 ZIF514RVZR |
| ALBUTEIN | ALBUMIN (HUMAN) | GRIFOLS USA, LLC | d18a7e13-1ef0-495c-aa57-ace2e446a823 | 2025-05-28 | Warnings, Adverse reactions | ZIF514RVZR |
| ALBUTEIN | ALBUMIN (HUMAN) | GRIFOLS USA, LLC | 9c45986e-4e62-4f7d-971c-bec74dc4d234 | 2025-05-28 | Warnings, Adverse reactions | ZIF514RVZR |
| HUMAN ALBUMIN GRIFOLS | ALBUMIN (HUMAN) | GRIFOLS USA, LLC | a43c5ed6-7423-4ee5-8acb-5fccc2d7b6cc | 2025-02-11 | Warnings, Adverse reactions | ZIF514RVZR |
| ALBUMINEX | ALBUMIN HUMAN | BPL | 8428d373-f4b1-4e3b-bb19-ea89048f7c79 | 2024-12-31 | Warnings, Adverse reactions | ZIF514RVZR |
| ALBUMINEX | ALBUMIN HUMAN | BPL | 167f48d0-8ae5-4f7e-b050-9673dad78acc | 2024-12-31 | Warnings, Adverse reactions | ZIF514RVZR |
| Flexbumin | ALBUMIN HUMAN | Takeda Pharmaceuticals America, Inc. | 79094f4e-5f5c-44d6-b563-d6078eafe83a | 2024-12-18 | Warnings, Adverse reactions | ZIF514RVZR |
| FLEXBUMIN | ALBUMIN HUMAN | Takeda Pharmaceuticals America, Inc. | bdb4e167-27a2-4b50-b245-43df9cd535cb | 2024-12-18 | Warnings, Adverse reactions | 1741375 1741380 ZIF514RVZR |
| AlbuRx | ALBUMIN (HUMAN) | CSL Behring AG | ad74b7f5-b380-47ab-b19d-eef92c8eb7a4 | 2022-08-04 | Warnings, Adverse reactions | 1741375 1741380 ZIF514RVZR |
| Albumin (Human) | ALBUMIN HUMAN | Octapharma USA Inc | 18a9c174-f892-e45f-ca4b-bd5a180c1539 | 2020-04-06 | Warnings, Adverse reactions | ZIF514RVZR |
| Albumin (Human) | ALBUMIN HUMAN | Octapharma USA Inc | bfea0d08-0e7f-a057-7b70-49b909b05a6a | 2020-04-06 | Warnings, Adverse reactions | ZIF514RVZR |
| Albumin (Human) | ALBUMIN HUMAN | Octapharma USA Inc | 07734008-9dd3-b006-0825-65147c58e1ac | 2020-04-06 | Warnings, Adverse reactions | 1741375 1741380 ZIF514RVZR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.